NCT01078662 Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats Status COMPLETED Phase PHASE2
NCT00972205 Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors Status COMPLETED Phase NA
NCT00845078 Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer Status WITHDRAWN Phase N/A
NCT00277069 Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00277004 Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer. Status TERMINATED Phase N/A
NCT00064857 Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors Status COMPLETED Phase PHASE2
NCT00026689 Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols Status COMPLETED Phase N/A